Articles with "ginsenoside rg2" as a keyword



Photo from wikipedia

Antidepressant-like effects of ginsenoside Rg2 in a chronic mild stress model of depression

Sign Up to like & get
recommendations!
Published in 2017 at "Brain Research Bulletin"

DOI: 10.1016/j.brainresbull.2017.08.009

Abstract: Major depression is a common neuropsychiatric disease with high lifetime prevalence and high incidence of suicide. This study aimed to evaluate the antidepressant effects of ginsenoside Rg2 in mice, and the possible mechanism was also… read more here.

Keywords: effects ginsenoside; like effects; chronic mild; mild stress ... See more keywords

Ginsenoside Rg2 Ameliorating CDAHFD-Induced Hepatic Fibrosis by Regulating AKT/mTOR-Mediated Autophagy.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of agricultural and food chemistry"

DOI: 10.1021/acs.jafc.1c07578

Abstract: Ginsenoside Rg2 (G-Rg2) in the rhizome of Panax ginseng can modify lipid accumulation, oxidative stress, and apoptosis in the liver induced by a high-fat diet. This research adds to this by assessing the potential antifibrosis… read more here.

Keywords: ginsenoside rg2; cdahfd induced; mtor mediated; akt mtor ... See more keywords
Photo by nate_dumlao from unsplash

Ginsenoside Rg2 alleviates myocardial fibrosis by regulating TGF-β1/Smad signalling pathway.

Sign Up to like & get
recommendations!
Published in 2021 at "Pharmaceutical biology"

DOI: 10.1080/13880209.2020.1867197

Abstract: CONTEXT Panax ginseng C.A. Meyer (Araliaceae) has cardioprotective effects. Ginsenosides are responsible for most of the pharmacological activities of ginseng. OBJECTIVE This study investigates the effect of ginsenoside Rg2 on myocardial fibrosis in myocardial ischaemia… read more here.

Keywords: smad signalling; myocardial fibrosis; ginsenoside rg2; tgf smad ... See more keywords

Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats

Sign Up to like & get
recommendations!
Published in 2022 at "BioMed Research International"

DOI: 10.1155/2022/8866660

Abstract: Aim Trastuzumab (TZM) is a monoclonal antibody drug for HER2-positive breast cancer by targeting epidermal growth factor 2, but it has significant cardiotoxicity. Ginsenoside Rg2 has shown a variety of biological activities. This study was… read more here.

Keywords: ginsenoside rg2; induced cardiotoxicity; cardiotoxicity; tzm induced ... See more keywords